Nektar Therapeutics (NKTR) Posts Q3 Loss of $0.21, Sales Top Expectations
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- S&P 500, Nasdaq retreat from record highs as yields and oil climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
| Nektar Therapeutics (NASDAQ: NKTR) | Delayed: 39.17 -0.74 (1.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $39.91 | 52 Week High | $19.98 | |||
| Open | $39.22 | 52 Week Low | $10.52 | |||
| Day High | $40.35 | P/E | N/A | |||
| Day Low | $38.71 | EPS | $-1.45 | |||
| Volume | 510,191 | |||||
